BioProcess Theater, Day 1

10:00 AM–4:15 PM Jun 4, 2019 (US - Eastern)

BioProcess Theater: Booth #3211


Since 2008, the BPI Theater, a live, interactive amphitheater located at the heart of the BioProcess Zone (booth #3211), provides biopharmaceutical professionals with a dedicated destination to meet, network, listen and learn about the latest scientific, technology, business, and financial trends impacting biopharmaceutical research, development, and manufacturing.

In 2019, this live, three-day, complimentary event consists of targeted panel discussions and individual presentations focusing on:
Emerging Therapies: Cell & Gene Therapies, Viral Vectors/Vaccines, Manufacturing Strategies for Therapeutic Modalities, Capacity Challenges & Opportunities
Emerging Techniques & Technologies: Drug Product Supply Challenges, Speed to Market, Capacity vs. Cost, SUS vs, Stainless, Analytics & Formulation, Single-Use Bioprocessing
*Open to all attendees

Tuesday, June 4

BioProcess Insider Daily- One-on-One Live Executive Interviews
10:00 am - 11:00 am

Kicking off the BPI Theater on both Tuesday and Wednesday mornings are face to face interviews conducted by Dan Stanton, veteran industry journalist and editor of BioProcess Insider

10:00 am - 10:15 am: Konstantin Matenzoglu, CEO, CELONIC Group

10:15 am - 10:30 am: Catarina Flyborg, GM, Cell and Gene Therapy Business, GE Healthcare

10:30 am - 10:45 am: Maurice Phelan, Site Head of Cambridge US, Sartorius Stedim Biotech

10:45 am - 11:00 am: Jennifer Cannon, VP of Operations Commercial Development, ABBVIE

The Cocoon Platform, a Kaleidoscope Approach to Cell Therapy Manufacturing

11:00 am - 11:20 am

Speaker: Matthew M. Hewitt Ph.D., Head of Clinical Development, Lonza Walkersville

Standardized Plasmids for Viral Vector Production

11:20 am - 11:40 am

Speaker: James Brown, Ph.D., Vice President of Corporate Development, Aldevron

Moving Gene Therapies to Market: The Role of Manufacturing Technologies
11:40 am - 12:00 pm

Speaker: Clive Glover, Director of Strategy, Gene and Cell Therapy, Pall Biotech

Cell/Gene/Immuno-Oncology Therapy Modalities - Why Develop One Modality Type vs. Another? How Does This Impact Manufacturing Strategies?

12:00 pm - 12:45 pm

Chair: Patricia Seymour, Managing Director, BPTG, BDO USA


Al Gianchetti, President and CEO, XyloCor
Alan Moore, VP & Commercial Chief for Advanced Therapies, WuXi Advanced Therapies
Susan Jones, SVP Development, Harpoon
Diane Blumenthal, Head of Technical Operations, Spark Therapeutics, Inc.

Gene Therapy Product Analysis: Where Historical and Modern Techniques Meet

12:45 pm - 1:05 pm

Speaker: Dr. Andy Topping, CSO, FUJIFILM Diosynth Technologies

Single-Use Stir Tank Bioreactors: A Commercially Viable Strategy for Cell Therapy Manufacturing

1:05 pm - 1:25 pm

Speaker: Alex Klarer, Biomedical Engineer, Hitachi Chemical Advanced Therapeutics Solutions

*Sponsored by: Distek

Emerging Therapy Development: Raising the Probability of Success

1:25 pm - 1:45 pm

Speaker: Maurice Phelan, Site Head of Cambridge US, Cell Line & Testing Solutions, Sartorius Stedim Biotech


Cell and Gene Therapies: Keep it in-house or use a third-party?

1:45 pm - 2:30 pm

Chair: Dan Stanton, BioProcess Insider


Bruce Levine, President Elect, ISCT
Joseph Rininger, Ph.D., Director, Cell Gene Therapy, Latham Biopharm Group
Felix Hsu, SVP and Global Head, WuXi Advanced Therapies
Soenke Brunswieck, Head of Cell Gene Therapy, CELONIC Group
Joe Vitale, Ph.D., Director, Account Management, Hitachi Chemical

Process Development of a Closed CAR T Manufacturing Process

2:30 pm- 2:50 pm

Speaker: Rohin Ilyer, Ph.D., Development Manager, Cell Therapy, GE Healthcare


Harnessing AI & Machine Learning to Improve R&D Efficiency and Reproducibility

2:50 pm - 3:30 pm

Chair: Mike Ward, Chief Content Officer, Informa Pharma Intelligence


Magdalena Paluch, Co-Founder & CEO, LabTwin GmbH
Ron Alfa, SVP, Translational Discovery Recurison Pharmaceuticals
John Piccone, ZS Associates
Krishnan Nandabalan, President & CEO, InveniAI Corporation
Seth Lederman, CEO & Chariman, TONIX Pharmaceuticals


Start-Up Sourcebook: How to Jump 5 Unforeseen Hurdles to Biotech Success

3:30 pm - 4:15 pm

Chair: Lisa LaMotta, Associate Director of Marketing and Communications, SmartLabs


Panelist: Ramani Varanasi, CEO, X-Biotix Therapeutics
Panelist: Chris Haskell, Head of West Coast Innovation Center, Bayer Healthcare
Panelist: Dan Geffken, Co-Founder, Danforth Advisors
Panelist: Luba Greenwood, Business Development & Corporate Ventures, Google’s Verily
Panelist: Ailis Tweed-Kent, CEO, Cocoon Biotech
Panelist: Teresa Lavoie, Principal, Fish & Richardson

Session ID: 553318